Publications

Becky Pennington, Jack Eaton, Anthony Hatswell, Helen Taylor (2022). Carers Health-Related Quality of Life in Global Health Technology Assessment: Guidance, Case Studies and Recommendations. PharmacoEconomics.

Anthony Hatswell, Kevin Deighton, Julia Thornton Snider, M. Alan Brookhart, Anik R. Patel (2022). Approaches to Selecting "Time Zero" in External Control Arms with Multiple Potential Entry Points, A Simulation Study of 8 Approaches. Medical Decision Making.

Ioannis Tomazos, Anthony Hatswell, Spero Cataland, Peter Chen, Nick Freemantle, Åsa Lommele, Kevin Deighton, Emma Knowles, Neil S Sheerin, Eric Rondeau (2022). Comparative efficacy of ravulizumab and eculizumab in the treatment of atypical hemolytic uremic syndrome: An indirect comparison using clinical trial data. Clinical Nephrology.

Anthony Hatswell (2022). Smaller science company? Tailor your CV for a manager, not HR. Nature.

Anthony Hatswell, Ash Bullement, Michael Schlichting, Murtuza Bharmal (2020). What is the Impact of the Analysis Method Used for Health State Utility Values on QALYs in Oncology? A Simulation Study Comparing Progression-Based and Time-to-Death Approaches. Applied Health Economics and Health Policy.

Anthony Hatswell, Nick Freemantle, Gianluca Baio, Emmanuel Lesaffre, Joost van Rosmalen (2020). Summarising salient information on historical controls: A structured assessment of validity and comparability across studies. Clinical Trials.

Caroline Farmer, Ash Bullement, David Packman, Linda Long, Sophie Robinson, Elham Nikram, Anthony J. Hatswell, G. J. Melendez-Torres, Louise Crathorne (2020). Voretigene Neparvovec for Treating Inherited Retinal Dystrophies Caused by RPE65 Gene Mutations: An Evidence Review Group Perspective of a NICE Highly Specialised Technology Appraisal. PharmacoEconomics.

Ash Bullement, Anna Willis, Amerah Amin, Michael Schlichting, Anthony James Hatswell, Murtuza Bharmal (2020). Evaluation of survival extrapolation in immuno-oncology using multiple pre-planned data cuts: learnings to aid in model selection. BMC Medical Research Methodology.

Ash Bullement, Matthew Taylor, Sam Thomas McMordie, Errol Waters, Anthony James Hatswell (2019). NICE, in Confidence: An Assessment of Redaction to Obscure Confidential Information in Single Technology Appraisals by the National Institute for Health and Care Excellence. PharmacoEconomics.

Ash Bullement, Holly L. Cranmer, Gemma E. Shields (2019). A Review of Recent Decision-Analytic Models Used to Evaluate the Economic Value of Cancer Treatments. Applied Health Economics and Health Policy.

Ash Bullement, Samuel Thomas McMordie, Anthony James Hatswell, Nanxin Li, Koo Wilson (2019). Carers Health-Related Quality of Life in Global Health Technology Assessment: Guidance, Case Studies and Recommendations. PharmacoEconomics.

Anthony J Hatswell, William G Sullivan (2019). Creating historical controls using data from a previous line of treatment – Two non-standard approaches. Statistical Methods in Medical Research.

Ash Bullement, Paul Nathan, Anna Willis, Amerah Amin, Cameron Lilley, Ceilidh Stapelkamp, Anthony Hatswell, Chris Pescott, Murtuza Bharmal (2019). Cost Effectiveness of Avelumab for Metastatic Merkel Cell Carcinoma. PharmacoEconomics.

Ash Bullement, Nicholas R. Latimer, Helen Bell Gorrod (2018). Survival Extrapolation in Cancer Immunotherapy: A Validation-Based Case Study. Value in Health.

Ash Bullement, Yang Meng, Miranda Cooper, Dawn Lee, Tara Louise Harding, Chris O’Regan, Raquel Aguiar-Ibanez (2018). A review and validation of overall survival extrapolation in health technology assessments of cancer immunotherapy by the National Institute for Health and Care Excellence: how did the initial best estimate compare to trial data subsequently made available?. Journal of Medical Economics.

Anthony James Hatswell MSc, Nick Freemantle PhD, Gianluca Baio PhD (0001). Carers Health-Related Quality of Life in Global Health Technology Assessment: Guidance, Case Studies and Recommendations. Value in Health.